anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Surpass
Unknown small_molecule active
Quick answer
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy for Effect Increased is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Effect Increased
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active